MIT Biotechnology Group

Intellia Therapeutics Scientist

Intellia Therapeutics was founded in 2014 by Caribou Biosciences and Atlas Venture, along with a consortium of leading scientists who have helped define the space. Intellia Therapeutics holds exclusive access to a broad intellectual property portfolio covering the application of CRISPR/Cas9 technology for human therapeutic use. As we build our team, we’re looking for people who share our commitment and energy to make a difference. See our current openings below.

TITLE: Computational Biologist/Bioinformatician

APPLY: http://grnh.se/te6l5b

 

TITLE: Research Scientist I, Hematopoietic Stem Cell Biology

APPLY: http://grnh.se/l0c3on

 

TITLE: Research Associate, Screening & Molecular Biology

APPLY: http://grnh.se/6fnhm1

 

TITLE: Senior Research Associate, Ex Vivo Biology

APPLY: http://grnh.se/u48oxg

Post expires at 1:02pm on Thursday January 19th, 2017